240 related articles for article (PubMed ID: 18048928)
1. Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin.
Sterk M; Müller J; Hemphill A; Müller N
Microbiology (Reading); 2007 Dec; 153(Pt 12):4150-4158. PubMed ID: 18048928
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole.
Müller J; Ley S; Felger I; Hemphill A; Müller N
J Antimicrob Chemother; 2008 Jul; 62(1):72-82. PubMed ID: 18408240
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.
Müller J; Sterk M; Hemphill A; Müller N
J Antimicrob Chemother; 2007 Aug; 60(2):280-7. PubMed ID: 17561498
[TBL] [Abstract][Full Text] [Related]
4. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
[TBL] [Abstract][Full Text] [Related]
5. A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.
Müller J; Wastling J; Sanderson S; Müller N; Hemphill A
Antimicrob Agents Chemother; 2007 Jun; 51(6):1979-86. PubMed ID: 17438059
[TBL] [Abstract][Full Text] [Related]
6. Rapid detachment of Giardia lamblia trophozoites as a mechanism of antimicrobial action of the isoflavone formononetin.
Lauwaet T; Andersen Y; Van de Ven L; Eckmann L; Gillin FD
J Antimicrob Chemother; 2010 Mar; 65(3):531-4. PubMed ID: 20067984
[TBL] [Abstract][Full Text] [Related]
7. Antigiardial activity of isoflavones from Dalbergia frutescens bark.
Khan IA; Avery MA; Burandt CL; Goins DK; Mikell JR; Nash TE; Azadegan A; Walker LA
J Nat Prod; 2000 Oct; 63(10):1414-6. PubMed ID: 11076565
[TBL] [Abstract][Full Text] [Related]
8. Aminoguanidines: New leads for treatment of Giardia duodenalis infection.
Abraham RJ; Abraham S; Stevens AJ; Page SW; McCluskey A; Trott DJ; O'Handley RM
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():38-44. PubMed ID: 31015151
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target.
Leitsch D; Müller J; Müller N
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):148-153. PubMed ID: 27485086
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel antigiardiasis drug candidates.
Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2).
Müller J; Schildknecht P; Müller N
J Antimicrob Chemother; 2013 Aug; 68(8):1781-9. PubMed ID: 23580565
[TBL] [Abstract][Full Text] [Related]
12. Experimental verification of the identity of variant-specific surface proteins in Giardia lamblia trophozoites.
Li W; Saraiya AA; Wang CC
mBio; 2013 May; 4(3):e00321-13. PubMed ID: 23695837
[TBL] [Abstract][Full Text] [Related]
13. The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target.
Kunz S; Balmer V; Sterk GJ; Pollastri MP; Leurs R; Müller N; Hemphill A; Spycher C
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005891. PubMed ID: 28915270
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide induced cytotoxicity and cell cycle arrest in Giardia trophozoites.
Haldar T; Sardar SK; Ghosal A; Prasad A; Nakano YS; Dutta S; Nozaki T; Ganguly S
Exp Parasitol; 2024 Jul; 262():108773. PubMed ID: 38723845
[TBL] [Abstract][Full Text] [Related]
15. vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro.
Bienz M; Siles-Lucas M; Wittwer P; Müller N
Infect Immun; 2001 Sep; 69(9):5278-85. PubMed ID: 11500396
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Small-Gatekeeper Kinases as Drug Targets in Giardia lamblia.
Hennessey KM; Smith TR; Xu JW; Alas GC; Ojo KK; Merritt EA; Paredez AR
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005107. PubMed ID: 27806042
[TBL] [Abstract][Full Text] [Related]
17. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.
Nillius D; Müller J; Müller N
J Antimicrob Chemother; 2011 May; 66(5):1029-35. PubMed ID: 21393225
[TBL] [Abstract][Full Text] [Related]
18. An image-based assay for high throughput screening of Giardia lamblia.
Gut J; Ang KK; Legac J; Arkin MR; Rosenthal PJ; McKerrow JH
J Microbiol Methods; 2011 Mar; 84(3):398-405. PubMed ID: 21262276
[TBL] [Abstract][Full Text] [Related]
19. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
[No Abstract] [Full Text] [Related]
20. Physiological aspects of nitro drug resistance in Giardia lamblia.
Müller J; Hemphill A; Müller N
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):271-277. PubMed ID: 29738984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
